Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


27.03.2017

1 Am J Nurs
2 Anticancer Res
1 Appl Clin Inform
1 Br J Cancer
1 Cancer Causes Control
1 Cancer Prev Res (Phila)
1 Curr Urol Rep
1 Georgian Med News
2 Int Braz J Urol
2 Int J Radiat Oncol Biol Phys
1 Int Urol Nephrol
1 J Laparoendosc Adv Surg Tech A
1 Jpn J Clin Oncol
2 Onco Targets Ther
2 Pathol Res Pract
1 PLoS One
2 Prog Urol
1 World J Surg Oncol
1 Zhonghua Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Nurs

  1. ASCHENBRENNER DS
    Updated Review Confirms Potential Risk of Bladder Cancer with Pioglitazone.
    Am J Nurs. 2017;117:25.
    PubMed     Text format    


    Anticancer Res

  2. RADES D, Manig L, Janssen S, Schild SE, et al
    A Survival Score for Patients Assigned to Palliative Radiotherapy for Metastatic Bladder Cancer.
    Anticancer Res. 2017;37:1481-1484.
    PubMed     Text format     Abstract available

  3. RADES D, Manig L, Janssen S, Schild SE, et al
    Concurrent Chemotherapy Improves the Overall Survival of Patients Irradiated for Locally Recurrent Bladder Cancer.
    Anticancer Res. 2017;37:1485-1488.
    PubMed     Text format     Abstract available


    Appl Clin Inform

  4. MURPHY DR, Meyer AN, Vaghani V, Russo E, et al
    Application of Electronic Algorithms to Improve Diagnostic Evaluation for Bladder Cancer.
    Appl Clin Inform. 2017;8:279-290.
    PubMed     Text format     Abstract available


    Br J Cancer

  5. SAKAGUCHI T, Yoshino H, Yonemori M, Miyamoto K, et al
    Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Br J Cancer. 2017 Mar 21. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer Causes Control

  6. SUN X, Hoadley KA, Kim WY, Furberg H, et al
    Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer.
    Cancer Causes Control. 2017 Mar 20. doi: 10.1007/s10552-017-0885.
    PubMed     Text format     Abstract available


    Cancer Prev Res (Phila)

  7. GEE JR, Saltzstein DR, Kim K, Kolesar JM, et al
    A phase II randomized, double-blind, presurgical trial of Polyphenon E in bladder cancer patients to evaluate pharmacodynamics and bladder tissue biomarkers.
    Cancer Prev Res (Phila). 2017 Mar 21. pii: canprevres.0167.2016.
    PubMed     Text format     Abstract available


    Curr Urol Rep

  8. PIETZAK EJ
    The Impact of Blue Light Cystoscopy on the Diagnosis and Treatment of Bladder Cancer.
    Curr Urol Rep. 2017;18:39.
    PubMed     Text format     Abstract available


    Georgian Med News

  9. NIKOLEISHVILI D, Tchanturaia Z, Managadze G, Koberidze G, et al
    THE FIRST REPORT OF LAPAROSCOPIC RADICAL CYSTECTOMY IN GEORGIA.
    Georgian Med News. 2016;:7-11.
    PubMed     Text format     Abstract available


    Int Braz J Urol

  10. MONTEIRO LL, Kassouf W
    Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: Yes.
    Int Braz J Urol. 2017;43:184-187.
    PubMed     Text format    

  11. MITIN T
    Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: No.
    Int Braz J Urol. 2017;43:188-191.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  12. VASHISTHA V, Wang H, Mazzone A, Liss MA, et al
    Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2017;97:1002-1020.
    PubMed     Text format     Abstract available

  13. MICHAELSON MD, Hu C, Pham HT, Dahl DM, et al
    A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 05
    Int J Radiat Oncol Biol Phys. 2017;97:995-1001.
    PubMed     Text format     Abstract available


    Int Urol Nephrol

  14. BOTHIG R, Kurze I, Fiebag K, Kaufmann A, et al
    Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre.
    Int Urol Nephrol. 2017 Mar 22. doi: 10.1007/s11255-017-1570.
    PubMed     Text format     Abstract available


    J Laparoendosc Adv Surg Tech A

  15. PYUN JH, Kim HK, Cho S, Kang SG, et al
    Robot-Assisted Radical Cystectomy with Total Intracorporeal Urinary Diversion: Comparative Analysis with Extracorporeal Urinary Diversion.
    J Laparoendosc Adv Surg Tech A. 2016;26:349-55.
    PubMed     Text format     Abstract available


    Jpn J Clin Oncol

  16. FUJII N, Hoshii Y, Hirata H, Mori J, et al
    Impact of divergent differentiation in urothelial carcinoma on oncological outcome in patients with T1 high-grade bladder cancer.
    Jpn J Clin Oncol. 2017 Mar 8:1-8. doi: 10.1093.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  17. CHEN W, Zhao K, Miao C, Xu A, et al
    Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-beta/Smad2/3 signaling pathway in bladder cancer cells.
    Onco Targets Ther. 2017;10:1503-1512.
    PubMed     Text format     Abstract available

  18. AYDIN AM, Woldu SL, Hutchinson RC, Boegemann M, et al
    Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer.
    Onco Targets Ther. 2017;10:1487-1502.
    PubMed     Text format     Abstract available


    Pathol Res Pract

  19. MAKBOUL R, Refaiy A, Abdelkawi IF, Hameed DA, et al
    Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma.
    Pathol Res Pract. 2016;212:385-92.
    PubMed     Text format     Abstract available

  20. YASUI M, Morikawa T, Nakagawa T, Miyakawa J, et al
    Urinary bladder carcinoma with divergent differentiation featuring small cell carcinoma, sarcomatoid carcinoma, and liposarcomatous component.
    Pathol Res Pract. 2016;212:833-7.
    PubMed     Text format     Abstract available


    PLoS One

  21. VAN KESSEL KE, van de Werken HJ, Lurkin I, Ziel-van der Made AC, et al
    A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable.
    PLoS One. 2017;12:e0174039.
    PubMed     Text format     Abstract available


    Prog Urol

  22. CHANU T, Neuzillet Y, Butreau M, Bach C, et al
    [Predictive factors and prognostic consequences of perioperative complications of radical cystectomies for urothelial carcinoma in patients of 80 years or more].
    Prog Urol. 2016;26:331-8.
    PubMed     Text format     Abstract available

  23. BELOT PY, Fassi-Fehri H, Colombel M, Matillon X, et al
    [The W-shaped ileal neobladder: Long term functional outcomes and health-related quality of life].
    Prog Urol. 2016;26:367-74.
    PubMed     Text format     Abstract available


    World J Surg Oncol

  24. CAO W, Ma E, Zhou L, Yuan T, et al
    Exploring the FGFR3-related oncogenic mechanism in bladder cancer using bioinformatics strategy.
    World J Surg Oncol. 2017;15:66.
    PubMed     Text format     Abstract available


    Zhonghua Yi Xue Za Zhi

  25. NIU HT, Dong P, Wang JN, Huang J, et al
    [Analysis of treatment and prognosis in post-operative patients with urachal carcinoma].
    Zhonghua Yi Xue Za Zhi. 2016;96:1923-5.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: